FDA Panel Gets Varied Opinions on DTC Genomics

The Molecular and Clinical Genetics Panel held a public meeting this week to discuss potential strategies for regulating some DTC genetic tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.